SCHEMBL21099083

SCHEMBL21099083

c1ccc(-c2cc(-c3ccc(-c4ccc(-c5cc(-c6cccnc6)cc(-c6cccnc6)c5)c5ccccc45)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.53
DHODH Q02127 1/20 0.51
CYP11B1 P15538 2/20 0.47
ALDH1A1 P00352 6/20 0.46
MAPT P10636 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NTSR1 P30989 1/20 0.46
HPGD P15428 1/20 0.46
CYP1A2 P05177 4/20 0.46
CYP3A4 P08684 4/20 0.46
TSHR P16473 4/20 0.46
CLK4 Q9HAZ1 3/20 0.46
GLA P06280 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP17A1 P05093 1/20 0.45
CYP11B2 P19099 1/20 0.45
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21099057 0.93 CYP11B1 (0.50) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL19486659 0.89 CYP19A1 (0.50) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL19486668 0.89 CYP19A1 (0.50) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL17918142 0.89 CYP19A1 (0.50) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL28674039 0.88 CYP19A1 (0.67) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL19168447 0.88 CYP19A1 (0.47) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL19650615 0.88 DHODH (0.53) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL20009947 0.87 CYP19A1 (0.62) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL23095095 0.87 ALDH1A1 (0.50) CYP19A1DHODHCYP11B1ALDH1A1MAPT
SCHEMBL17917871 0.87 ALDH1A1 (0.50) CYP19A1DHODHCYP11B1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323006-B2 Heterocyclic compound and organic light emitting element using same LG CHEM, LTD. (KR) 2019-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323006-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, NR2E3 CYP19A1 121/4885DHODH 113/4885CYP11B1 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.